MedTrace Logo

Ultrasound Percapsular Nerve Group Block VS Fascia Iliaca Block for Hip Fracture

NCT04285333 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 88

Last updated 2024-02-13

No results posted yet for this study

Summary

Spinal anesthesia (SA) is a widely accepted anesthetic technique for hip fracture repair among elderly. Positioning for SA can be extremely painful. Effective management of pain is important for these patients comfort.

Fascia Iliaca block (FIB) and Femoral nerve blocks are commonly used for analgesia in hip fracture patients. However, they often provide a modest reduction in pain.

The Percapsular Nerve Group block (PENG Block) has the advantage that it covers the accessory obturator nerve.

Aim of the study: compare FIB with PENG prior to positioning hip fracture patients for standardized SA.

In a prospective randomized double blind we included 80 patients aged more than 65 years old, for whom pain was felt when raising the affected limb to 15 degrees. Patients were assigned to receive either ultrasound guided Fascia Iliaca block or Percapsular Nerve Group block using 20 mL Lidocaine 1.5% in both groups. We compared pain on positioning for spinal anesthesia using Verbal Rating Scale (VRS 0 = no pain , VRS 1 = mild pain, t 2= severe pain) for both groups. We also recorded different times to perfom block.

Conditions

  • Hip Fracture
  • Analgesia
  • Acute Pain

Interventions

PROCEDURE

fascia iliaca block

ultrasound guided block with 20 mL lidocaine 1.5%

PROCEDURE

percapsular nerve group block

ultrasound guided block with 20 mL lidocaine 1.5%

Sponsors & Collaborators

  • Institut Kassab d'Orthopédie

    collaborator OTHER

  • University Tunis El Manar

    lead OTHER

Principal Investigators

  • khaireddine Raddaoui, MD · Tunis El Manar University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-17
Primary Completion
2020-04-30
Completion
2022-05-31

Countries

  • Tunisia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04285333 on ClinicalTrials.gov